Bioactivity | NOD1 antagonist-2 (compound 66) is an orally active selective antagonist of both human and mouse NOD1. NOD1 antagonist-2 (compound 66) antagonizes NOD1-induced NF-κB and MAPK pathways[1]. |
Invitro | NOD1 antagonist-2 (compound 66) 在对HEK293细胞中的h/mNOD1诱导的NF-κB激活表现出有前景的拮抗活性 (IC50 分别为0.8 nM和32 nM)[1]。NOD1 antagonist-2 (compound 66, 0.1, 1 μM) 显著抑制了THP-1细胞和骨髓来源的巨噬细胞 (mBMDMs) 中p-RIP2)、p-p65、p-p38 和 p-JNK 水平的增加,这表明它在调节NOD1诱导的信号传导途径中具有有效性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> NOD1 antagonist-2 相关抗体: |
In Vivo | NOD1 antagonist-2 (compound 66, orally) 抑制免疫细胞和上皮细胞中炎症细胞因子 (IL-6, TNF-α) 和化学趋化因子 (CXCL1, CXCL8) 的表达,以及在幽门螺杆菌诱导的小鼠模型中炎症细胞因子 (KC, IL-6) 的表达[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
Formula | C21H13Cl2F2N3O5S2 |
Molar Mass | 560.38 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Xinhua Liu, et al. Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection. J Med Chem. 2024 Dec 26;67(24):22145-22167. |